RT

RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

Develops and produces IVD products for molecular biology and microbiology.

RTALB | IS

Overview

Corporate Details

ISIN(s):
TRERTAL00018
LEI:
Country:
Türkiye
Address:
N/A

Description

RTA Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş. specializes in the research, development, and production of in-vitro diagnostic (IVD) products. The company's core activities are focused on the fields of molecular biology and microbiology. Its molecular biology portfolio includes Real-Time PCR kits and nucleic acid isolation kits for both clinical and research applications. The microbiology division offers a comprehensive range of products, including various culture media (Petri dishes, chromogenic media), rapid tests, blood culture bottles, staining kits, and specific diagnostic tools for tuberculosis. The company emphasizes innovation through its dedicated research and development department, which leverages advanced molecular biotechnology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-07-07 11:08
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish HTML 14.5 KB
2025-07-04 17:13
2025 Yılı Bağımsız Denetim Şirketinin Genel Kurulda Onaylanması
Turkish HTML 29.3 KB
2025-07-04 17:13
Yönetim Kurulu Kar Dağıtımı Yapılmaması Önerisinin Kabul Edilmesi Hk.
Turkish HTML 24.2 KB
2025-07-04 17:10
RTALB 2024 Yılı 2. Olağan Genel Kurul Toplantısının Tamamlanması Hk.
Turkish PDF 414.9 KB
2025-07-04 17:10
RTALB 2024 Yılı 2. Olağan Genel Kurul Toplantısının Tamamlanması Hk.
Turkish PDF 672.0 KB
2025-07-04 17:10
RTALB 2024 Yılı 2. Olağan Genel Kurul Toplantısının Tamamlanması Hk.
Turkish HTML 13.9 KB
2025-06-04 17:10
2024 Yılı Olağan Genel Kurulu 2. Toplantısı Çağrısı Hk.
Turkish PDF 253.1 KB
2025-06-04 17:10
2024 Yılı Olağan Genel Kurulu 2. Toplantısı Çağrısı Hk.
Turkish PDF 290.9 KB
2025-06-04 17:10
2024 Yılı Olağan Genel Kurulu 2. Toplantısı Çağrısı Hk.
Turkish HTML 15.8 KB
2025-06-04 10:58
Olağan Genel Kurul Toplantısının Toplantı Nisabı Sağlanamaması Nedeniyle Ertele…
Turkish PDF 417.1 KB
2025-06-04 10:58
Olağan Genel Kurul Toplantısının Toplantı Nisabı Sağlanamaması Nedeniyle Ertele…
Turkish PDF 202.8 KB
2025-06-04 10:58
Olağan Genel Kurul Toplantısının Toplantı Nisabı Sağlanamaması Nedeniyle Ertele…
Turkish HTML 13.7 KB
2025-05-05 17:11
Yönetim Kurulu'nun Kar Payı Dağıtılmamasına İlişkin Teklifi
English HTML 22.4 KB
2025-05-05 17:11
2024 Yılı Olağan Genel Kurulu Daveti
Turkish PDF 291.9 KB
2025-05-05 17:11
2024 Yılı Olağan Genel Kurulu Daveti
Turkish PDF 253.3 KB

Automate Your Workflow. Get a real-time feed of all RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.